{
    "title": "First-ever licencing deal struck for cancer drug",
    "url": "https://www.dailymail.co.uk/wires/afp/article-11335515/First-licencing-deal-struck-cancer-drug.html",
    "date": "2022-10-20",
    "keywords": [
        "access",
        "health",
        "cancer",
        "treatment",
        "novartis",
        "drug",
        "leukaemia",
        "deal",
        "statement",
        "myeloid",
        "licensing",
        "agreement",
        "organisation",
        "nilotinib",
        "cml",
        "patent",
        "giant",
        "firstever",
        "opportunity",
        "manufacture",
        "supply",
        "medication",
        "highquality",
        "component",
        "response",
        "burden",
        "head",
        "poorer",
        "period",
        "precedent",
        "gore",
        "president",
        "sustainability",
        "lutz",
        "hegemann",
        "company",
        "model",
        "world",
        "list",
        "age",
        "suffering",
        "zeba",
        "oncologist",
        "hameed",
        "hospital",
        "lahore",
        "pakistan",
        "alternative",
        "firstline",
        "percent",
        "contract",
        "disease",
        "medicine",
        "licence",
        "middleincome",
        "indonesia",
        "morocco",
        "tunisia",
        "product",
        "force",
        "mpp",
        "coalition",
        "way",
        "cochair",
        "anil",
        "dcruz"
    ],
    "category": [
        "wires",
        "afp"
    ]
}